Showing results (1151-1160 of 1,337) with videos related to
Sort By:
Pageof 134
Hernia : the Journal of Hernias and Abdominal Wall Surgery|October 9, 2015
Short-term outcome after Onstep versus Lichtenstein technique for inguinal hernia repair: results from a randomized clinical trialK Andresen, J Burcharth, S Fonnes, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2015
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomasSigmund Ytre-Hauge, Jenny A Husby, Inger J Magnussen, et al.Nature Biotechnology|July 26, 2016
Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studiesDaryl M Gohl, Pajau Vangay, John Garbe, et al.Nanoscale|May 19, 2021
Prismatic Ge-rich inclusions in the hexagonal SiGe shell of GaP-Si-SiGe nanowires by controlled facetingRoberto Bergamaschini, Rianne C Plantenga, Marco Albani, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 2, 2024
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica-a prospective study of 101 patientsAndreas Wiggers Nielsen, Ib Tønder Hansen, Berit Dalsgaard Nielsen, et al.Scientific Reports|October 14, 2024
The validity and reliability of a Japanese version of the web-based hamstring outcome scoreShogo Tsutsumi, Noriaki Maeda, Anders Hauge Engebretsen, et al.The Journal of Endocrinology|September 18, 2024
The GHSR1a antagonist LEAP2 regulates islet hormone release in a sex-specific mannerNirun Hewawasam, Debalina Sarkar, Olivia Bolton, et al.Frontiers in Medicine|April 16, 2026
Correction: The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumaticaBerit D Nielsen, Salome Kristensen, Agnete Donskov, et al.Circulation|February 24, 2001
Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failureL Gullestad, H Aass, J G Fjeld, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 8, 2001
[Immunomodulating treatment in advanced heart failure--effect of intravenous immunoglobulin]L Gullestad, H Aass, A K Andreassen, et al.Pageof 134